Clinicopathologic variables and the expression status of LAG-3 in soft tissue sarcoma
| Clinicopathological parameters | LAG-3 expression | P | |
| Low n (%) | High n (%) | ||
| Age (years) | 0.100 | ||
| > 65 | 131 (87.9) | 18 (12.1) | |
| ≥ 65 | 10 (71.4) | 4 (28.6)a | |
| Gender | 0.165 | ||
| Male | 78 (83.0) | 16 (17.0) | |
| Female | 63 (91.3) | 6 (8.7) | |
| Tumor depth | 0.017* | ||
| Superficial | 102 (82.9) | 21 (17.1) | |
| Deep | 39 (97.5) | 1 (2.5)a | |
| Grade | < 0.001 ** | ||
| Low grade (G1+G2) | 114 (92.7) | 9(7.3) | |
| High grade (G3) | 27(67.5) | 13 (32.5) | |
| Site | 1.000 | ||
| Trunk & extremity | 47 (87.0) | 7 (13.0) | |
| Head/neck & intra-
abdominal | 94 (86.2) | 15 (13.8) | |
| Stage | 0.016 * | ||
| I+II | 119 (90.2) | 13 (9.8) | |
| III+IV | 22 (71.0) | 9 (29.0) | |
a: Fisher test was used when n < 5; * P < 0.05; ** P < 0.01